Testing new apps that connect people with dementia and researchers
At Alzheimer’s Research UK we’re always looking for ways to help people get involved with dementia research. That’s why we’re supporting Dementia Citizens, a new initiative from innovation foundation...
View ArticleClik here to view.
Learning from cancer research in the hunt for dementia treatments
On the final day of last month’s Alzheimer’s Association International Conference in Toronto, we heard from Dr Jane Ann Driver, a cancer scientist who moved disciplines and took the leap into dementia...
View ArticleClik here to view.
New research: What can our genes tell us about Alzheimer’s?
We’re often asked how genetic Alzheimer’s is. If a parent or grandparent has the disease, how likely am I to get it too? We know that around 99% of cases of Alzheimer’s are not directly inherited –...
View ArticleClik here to view.
One important myth to overturn another
Around 18 months ago, Alzheimer’s Research UK launched its first-ever awareness advertising campaign, with an arresting and urgent film designed to shake society by the lapels in how it thinks about...
View ArticleClik here to view.
In the news: What next for anti-amyloid Alzheimer’s drugs?
It’s been a long and agonising wait for clinical trial results to show whether a treatment called solanezumab could be the first new drug licenced for Alzheimer’s in over a decade. But today, hopes...
View ArticleClik here to view.
UK’s biggest dementia research endeavour starts to take shape
Today we’re proud to share with you the news that world-renowned Belgian scientist Prof Bart De Strooper will take the helm of the UK Dementia Research Institute (DRI), a multi-centre national...
View ArticleClik here to view.
Prime Minister supports revolutionary early diagnosis effort
In an announcement made today, Prime Minister Theresa May outlined a new focus on early diagnosis of disease under the Grand Challenge on Artificial Intelligence in the Industrial Strategy. The Prime...
View ArticleClik here to view.
What do fizzy drinks and TV watching have to do with brain health?
We often talk about brain health and dementia risk on this blog, and how it’s a complex mix of age, our genes and the lifestyles we lead. It’s also a highly active area of research, with scientists...
View ArticleClik here to view.
4 emerging non-drug approaches to tackle dementia
When we think about future treatments for dementia our minds may immediately think of new drugs. From vaccines to antibiotics, aspirin to statins, drugs have had a revolutionary impact on our health...
View ArticleClik here to view.
Looking for answers beyond the brain
Our brains don’t exist in isolation, separate from the rest of the body, but are connected in a variety of ways. While dementia is caused by diseases of the brain, researchers are looking for answers...
View ArticleClik here to view.
Does Down’s syndrome hold the key to cracking Alzheimer’s?
It can come as a surprise to know that having Down’s syndrome puts people at much higher risk of Alzheimer’s. In fact, the genetic rearrangement that causes Down’s syndrome is one of the greatest...
View ArticleClik here to view.
In the news: Alzheimer’s drug trial set back
We’ve heard disappointing news that the pharmaceutical companies Biogen and Eisai have halted two trials of the experimental Alzheimer’s drug, aducanumab. Early stage clinical trials of aducanumab had...
View ArticleClik here to view.
When will there be a blood test for Alzheimer’s?
Alzheimer’s and the other diseases that cause dementia develop in the brain decades before symptoms start to show. This poses a huge challenge for dementia researchers working hard to make...
View ArticleClik here to view.
In the news: Our recent letter to the editor of The Times
Yesterday, we read with empathic frustration the observation on dementia research progress at the end of The Times’ comment on research into hearing aids (Delaying Dementia, 16 July). It reads: “More...
View ArticleCOVID-19: A message for our supporters
We want to update all our supporters on how we’re responding to COVID-19, and how we are persevering with our important mission in extraordinary times. We’re acutely aware of the impact the outbreak...
View Article